Thomas White International’s AstraZeneca AZN Stock Holding History

Thomas White International’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$4.03M	Sell	28,164 -23	-0.1%	-$3.38K	0.84%	34
2023 Q1	$3.91M	Buy	28,187 +357	+1%	+$48K	0.83%	31
2022 Q4	$3.77M	Buy	27,830 +8,065	+41%	+$1.01M	0.83%	30
2022 Q3	$2.17M	Buy	19,765 +4,740	+32%	+$601K	0.51%	59
2022 Q2	$1.99M	Buy	15,025 +3,770	+33%	+$495K	0.4%	80
2022 Q1	$1.49M	Buy	11,255 +561	+5%	+$67.3K	0.25%	98
2021 Q4	$1.25M	Sell	10,694 -7,925	-43%	-$932K	0.2%	120
2021 Q3	$2.24M	Buy	18,619 +1,032	+6%	+$120K	0.33%	94
2021 Q2	$2.11M	Buy	17,587 +403	+2%	+$44.2K	0.29%	94
2021 Q1	$1.71M	Buy	17,184 +137	+0.8%	+$13.8K	0.25%	105
2020 Q4	$1.71M	Buy	17,047 +128	+0.8%	+$13.6K	0.27%	101
2020 Q3	$1.85M	Sell	16,919 -473	-3%	-$52.6K	0.34%	80
2020 Q2	$1.84M	Sell	17,392 -2,723	-14%	-$281K	0.36%	83
2020 Q1	$1.8M	Sell	20,115 -852	-4%	-$80.2K	0.4%	72
2019 Q4	$2.09M	Sell	20,967 -765	-4%	-$72K	0.35%	92
2019 Q3	$1.94M	Sell	21,732 -513	-2%	-$44.5K	0.35%	93
2019 Q2	$1.84M	Buy	+22,245	New	+$1.74M	0.32%	94

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Thomas White International's AZN Position: Q2 2023 in Review

Thomas White International reduced its AstraZeneca (AZN) stake by 0.08% in Q2 2023, selling an estimated $3.38K and leaving 28,164 shares worth $4.03M. The position accounts for 0.84% of the portfolio, ranked #34.

Thomas White International first reported a position in AZN in Q2 2019 and has held it in 17 quarters since. 1,091 funds tracked by Wall St. Rank hold AZN as of Q2 2023.

Thomas White International held 28,164 shares of AstraZeneca worth $4.03M as of Q2 2023.
Thomas White International sold 23 AstraZeneca shares in Q2 2023, an estimated $3.38K.
AstraZeneca made up 0.84% of Thomas White International's portfolio in Q2 2023, its #34 holding.
Thomas White International first reported a position in AstraZeneca in Q2 2019 and has held it in 17 quarters since.
1,091 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2023.

Based on Thomas White International's 13F filing for Q2 2023, filed 14 Aug 2023.